Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ERYSOL FOR ORAL SUSPENSION 200 mg/5 ml

Approval Number

SIN00126P

Drug Name

ERYSOL FOR ORAL SUSPENSION 200 mg/5 ml

Product Name

ERYSOL FOR ORAL SUSPENSION 200 mg/5 ml

Approval Date

March 18, 1988

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

GRANULE, FOR SUSPENSION

Route of Administration

ORAL

Medical Information

ATC Code

J01FA01

ATC Item Name

erythromycin

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN

Strength

200 mg/5 ml

Drug MonographErythromycin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy